Shares in PepGen were down more than 21% after the FDA placed a partial clinical hold on its lead drug PGN-EDODM1, for rare ...

Doctors warn that Bulgaria’s healthcare system still lacks a sustainable framework for genomic diagnostics, patients are paying the price ...

Even on a vegetarian diet, excess refined carbs and sedentary habits can lead to belly fat. A doctor explains how carb-heavy eating patterns trigger central obesity.

Doctor Amir Khan has shared important advice for those who suddenly jolt awake as they start to fall asleep. It turns out it ...

New review highlights evolving Pompe disease management, from screening to next-generation therapies and monitoring. Read ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

Late-breaking oral presentation to feature primary analysis from KYSA-8 registrational trial in stiff person syndrome (SPS) ...

Marking International Women’s Day, the Asian Institute of Nephrology and Urology in Banjara Hills has launched a dedicated Centre for Functional and Female Urology. This initiative ...

They found that after three years of follow-up, the group taking GLP-1 agonists like Novo Nordisk's semaglutide and Eli Lilly's tirzepatide were 14% less likely to develop substance use disorders ...

Asharq Al Awsat Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to ...

There are two points in life when the body undergoes the most significant changes.

A disease that was common in the Victorian era is steadily growing in cases again in the UK, with some researchers pointing to GLP-1 drugs as a potential culprit. However, people may not realise the ...